General

How to Verify Parkinson’s Disease Claims in 2026: NIH, FDA, and trial records, Evidence, and Red Flags

Learn how to test Parkinson's claims against NIH guidance, FDA indications, trial results, and fraud warnings.

Parkinson’s Disease FAQ for September 2026: Source-Checked Answers to Common Questions

Understand Parkinson's symptoms, diagnosis, treatment limits, newer options, and practical questions to raise with clinicians.

Parkinson’s Disease 2026 Guide: safety, access, and evidence limits; Key Facts and Questions to Ask

Learn how to assess Parkinson's treatment claims, monitor medication safety, and challenge Medicare coverage limits.

What Is New With Parkinson’s Disease in September 2026? Latest NIH, FDA, and trial records and Key Takeaways

Separate real September Parkinson's advances from unapproved drugs, early research, and experimental procedures.

Parkinson’s Disease August 2026 Update: What Changed, Why It Matters, and What to Watch Next

See which August Parkinson's findings may affect care, which remain experimental, and what evidence needs to come next.

Carbidopa Levodopa Update 2026: Evidence and Open Questions

A practical guide to B6 monitoring, newer levodopa delivery options, their trade-offs, and the questions still unresolved.

Levodopa Decision Guide: Options, Trade-Offs, and Follow-Up

Compare levodopa's stronger symptom relief with its risks, dosing choices, monitoring needs, and later options.

Parkinsons Explained: What Patients and Families Should Know

Understand Parkinson's symptoms, diagnosis, treatments, medication safety, and practical caregiving priorities.

Deep Brain Stimulation Restores Life Quality for Severe Tourette Patients

Severe Tourette syndrome can devastate a person's life—but deep brain stimulation offers meaningful symptom reduction when other treatments have failed.

Deep brain stimulation treats severe Tourette syndrome effective results

Deep brain stimulation offers severe Tourette syndrome patients significant tic reduction and improved quality of life when medications and therapy have failed.

What Is Drug-Induced Parkinsonism?

Medications like antipsychotics can trigger parkinsonian symptoms that mimic Parkinson's disease but often improve when the drug is changed or stopped.

What Is Vascular Parkinsonism?

Vascular parkinsonism causes movement problems through stroke damage rather than dopamine loss, making it distinct from Parkinson's disease.

What Is Secondary Parkinsonism?

Secondary parkinsonism stems from a treatable cause—not progressive neurodegeneration—and many patients recover when the underlying trigger is addressed.

What Is Atypical Parkinsonism?

Atypical parkinsonism is a group of rare neurological disorders that resemble Parkinson's disease but involve different brain damage and typically resist standard PD medications.

What Is Parkinsonism?

Parkinsonism is not one disease but a group of movement disorders with different causes and treatment options.

Carbidopa-Levodopa: Uses, Dosage, Side Effects and Wearing-Off

Carbidopa-levodopa remains the most effective Parkinson's medication, but its effectiveness often changes over years of use, requiring careful adjustment to maintain symptom control.

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.